OTC Markets OTCQB - Delayed Quote USD

BioCorRx Inc. (BICX)

0.2870

0.0000

(0.00%)

As of April 29 at 4:00:00 PM EDT. Market Open.

BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC

ANAHEIM, CA and LOUISVILLE, KY - March 10, 2025 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders and USWM LLC, a specialty pharmaceutical...

NewMediaWire last month

BICX
0.00%
Fusion Fuel Appoints Luisa Ingargiola to Board of Directors

DUBLIN, Feb. 27, 2025 (GLOBE NEWSWIRE) -- via IBN – Fusion Fuel Green PLC (Nasdaq: HTOO) ("Fusion Fuel" or the "Company"), a leading provider of gas and hydrogen energy solutions, today announced the appointment of Luisa Ingargiola to its Board of Directors, effective February 24, 2025. Ms. Ingargiola will serve as chairperson of the Audit Committee, replacing Rune Magnus Lundetrae, who will remain a member of the Board. She will also serve as a member of the Nominating Committee, Audit Committe

GlobeNewswire 2 months ago

BICX
0.00%
ALBT

HTOO
BioCorRx Reports Business Update for the Second Quarter of 2024

ANAHEIM, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended June 30, 2024, and reported on recent corporate developments. Additionally, BioCorRx Inc. announces the expansion of its intellectual property portfolio with a new international patent awarded from Israel for the treatment of weight loss. This pat

GlobeNewswire 8 months ago

BICX
0.00%
BioCorRx Reports Business Update for the First Quarter of 2024

ANAHEIM, CA - (NewMediaWire) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ende...

NewMediaWire 11 months ago

BICX
0.00%

Performance Overview

Return	BICX	S&P 500 (^GSPC)
YTD	-24.47%	-6.30%
1-Year	-61.73%	+9.44%
3-Year	-90.74%	+33.38%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

BioCorRx Inc. (BICX)

BioCorRx Pharmaceuticals Inc. Announces That it has Acquired LUCEMYRA(R) (lofexidine), an FDA-Approved Opioid Withdrawal Medication, From USWM, LLC

Fusion Fuel Appoints Luisa Ingargiola to Board of Directors

BioCorRx Reports Business Update for the Second Quarter of 2024

BioCorRx Reports Business Update for the First Quarter of 2024

Performance Overview